(17314989), J. R. D., (17314992), T. M., (17314995), H. F., (17314998), M. H., (17315001), R. N. S., (17315004), A. D. R., . . . (17315025), M. A. H. (2025). Supplementary Figure 2 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
Citace podle Chicago (17th ed.)(17314989), John R. Davies, et al. Supplementary Figure 2 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the SeAFOod Polyp Prevention Trial. 2025.
Citace podle MLA (9th ed.)(17314989), John R. Davies, et al. Supplementary Figure 2 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the SeAFOod Polyp Prevention Trial. 2025.